The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

Author： Cai H.   Griendling K.K.   Harrison D.G.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.9, 2003-09, pp. : 471-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific

By  

Current Drug Metabolism, Vol. 9, Iss. 8, 2008-01 ,pp. : 686-696

Bentham Science Publishers

Access to resources Recommend Favorite

NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases

By  

Current Drug Targets, Vol. 13, Iss. 2, 2012-02 ,pp. : 222-229

Bentham Science Publishers

Access to resources Recommend Favorite

A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase

By  

Current Medicinal Chemistry, Vol. 10, Iss. 17, 2003-09 ,pp. : 1759-1764

Bentham Science Publishers

Access to resources Recommend Favorite

NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive &bgr;-Cell Dysfunction and Metabolic Syndrome

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 495-501

Bentham Science Publishers

Access to resources Recommend Favorite

Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases

By  

Current Drug Targets, Vol. 15, Iss. 13, 2014-12 ,pp. : 1231-1246

Bentham Science Publishers

Access to resources Recommend Favorite